this post was submitted on 13 Jan 2026
3 points (100.0% liked)

China News

91 readers
3 users here now

A community for china news

founded 3 months ago
MODERATORS
rss@news.abolish.capital
Salamence@lemmy.zip
RedWizard@news.abolish.capital
3
China’s SciNeuro, Novartis sign US$1.7 billion licensing deal to develop Alzheimer’s drugs (www.scmp.com)
submitted 1 month ago by rss@news.abolish.capital to c/china@news.abolish.capital
0 comments fedilink hide all child comments
 

A partnership between China’s SciNeuro Pharmaceuticals and Swiss pharmaceutical giant Novartis on Monday has revived hopes for treating Alzheimer’s disease. The deal, worth nearly US$1.7 billion, grants Novartis exclusive worldwide rights to develop and commercialise SciNeuro’s antibody candidates to develop drugs for the progressive brain disease. SciNeuro’s novel amyloid beta targeted antibody programme leverages proprietary blood-brain barrier shuttle technology to help more of the drug cross...

From China - South China Morning Post via This RSS Feed.

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here